Related Experiment Video
Updated: Mar 14, 2026
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Indole-3-carbinol attenuates cisplatin-induced premature ovarian failure by activating Nrf2 through competitive
Fengyu Zhu1, Ruixin Zhang2, Zhuoying He2
1Department of Obstetrics and Gynecology, NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, the First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui 230022, China; Engineering Research Center of Biopreservation and Artificial Organs, Ministry of Education, Hefei, Anhui 230022, China.
Background:
Premature ovarian failure (POF) leads to female infertility and significantly increases long-term health risks. However, available drugs that can reverse this condition are lacking.
Purpose:
To elucidate the role of nuclear factor erythroid 2-related factor (Nrf2) in POF and the underlying molecular mechanism through which indole-3-carbinol (I3C) alleviates POF.
Methods:
We established a POF model in wild type and Nrf2 knockout (Nrf2-KO) mice via cisplatin injection. ML385 and siRNA were used to inhibit and knockdown Nrf2 in vitro, respectively. Protein levels were detected by WB or IHC staining. Ovarian fibrosis was assessed by Masson and Sirius red staining. Cell viability, lactate dehydrogenase (LDH) levels, lipid peroxidation and ROS were determined to assess ferroptosis.
Results:
Nrf2-KO ovaries presented decreased levels of glutathione peroxidase 4 (Gpx4) and solute carrier family 7 member 11 (Slac7a11), along with elevated oxidative stress and fibrosis, resembling cisplatin-induced damage. Nrf2 overexpression or I3C treatment attenuated cisplatin-induced ferroptosis in vitro, whereas Nrf2 knockdown or inhibition abolished the protective effect of I3C. Nrf2-KO mice exhibited POF phenotypes, and the protective effects of I3C were lost in these mice. Mechanistically, I3C activated Nrf2 by competitively binding to Keap1 residues Y334, S363, and R380. Further studies revealed that Nrf2 inhibits ferroptosis by regulating NNT to maintain redox balance. NNT overexpression reversed oxidative damage caused by Nrf2 loss.
Conclusion:
The core role and mechanism of Nrf2 in maintaining ovarian function and resisting cisplatin-induced POF were clarified. Moreover, a potential drug that alleviates ovarian damage by activating Nrf2 was identified.
Insights
Nuclear factor erythroid 2-related factor (Nrf2) protects against premature ovarian failure (POF) by regulating ferroptosis. Indole-3-carbinol (I3C) alleviates POF by activating Nrf2, offering a potential therapeutic strategy.
Area of Science:
- Reproductive biology
- Molecular toxicology
- Cellular redox homeostasis
Background:
- Premature ovarian failure (POF) causes infertility and increases long-term health risks.
- Current treatments for reversing POF are limited.
Purpose of the Study:
- To investigate the role of nuclear factor erythroid 2-related factor (Nrf2) in POF.
- To understand how indole-3-carbinol (I3C) alleviates POF through Nrf2.
Main Methods:
- Established POF mouse models using cisplatin.
- Utilized ML385 and siRNA to inhibit/knockdown Nrf2 in vitro.
- Assessed ovarian fibrosis, oxidative stress, and ferroptosis markers.
Main Results:
- Nrf2 deficiency exacerbated cisplatin-induced ovarian damage and ferroptosis.
- I3C treatment protected against ferroptosis by activating Nrf2.
- I3C's protective effects were lost in Nrf2-knockout mice.
- Nrf2 regulates ferroptosis via NNT to maintain redox balance.
Conclusions:
- Nrf2 is crucial for ovarian function and protection against cisplatin-induced POF.
- I3C activates Nrf2, suggesting it as a potential therapeutic agent for ovarian damage.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
02:26NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
02:34Inhibition of Cdk Activity
01:31Regulation of the Unfolded Protein Response